New Zealand markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.77+0.10 (+0.73%)
At close: 04:00PM EDT
13.79 +0.02 (+0.15%)
After hours: 06:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
4,263,762,000
4,263,762,000
4,027,478,000
3,569,006,000
3,197,812,000
Cost of revenue
1,426,678,000
1,426,678,000
1,244,072,000
1,106,846,000
994,308,000
Gross profit
2,837,084,000
2,837,084,000
2,783,406,000
2,462,160,000
2,203,504,000
Operating expenses
Research development
729,924,000
729,924,000
633,325,000
526,087,000
455,833,000
Selling general and administrative
1,053,819,000
1,053,819,000
997,309,000
886,361,000
875,663,000
Total operating expenses
2,527,183,000
2,527,183,000
2,237,985,000
1,936,840,000
1,805,437,000
Operating income or loss
309,901,000
309,901,000
545,421,000
525,320,000
398,067,000
Interest expense
119,535,000
119,535,000
116,973,000
122,432,000
130,806,000
Total other income/expenses net
-116,645,000
-116,645,000
-46,945,000
-99,274,000
106,321,000
Income before tax
52,791,000
52,791,000
375,090,000
302,571,000
366,235,000
Income tax expense
-91,406,000
-91,406,000
58,052,000
72,405,000
-9,936,000
Income from continuing operations
144,197,000
144,197,000
317,038,000
230,166,000
376,171,000
Net income
144,067,000
144,067,000
317,017,000
230,059,000
376,005,000
Net income available to common shareholders
144,067,000
144,067,000
317,017,000
230,059,000
376,005,000
Basic EPS
61.59
46.05
102.14
73.57
120.36
Diluted EPS
60.67
45.58
100.97
72.94
119.48
Basic average shares
3,114,752
3,128,900
3,103,618
3,127,002
3,124,012
Diluted average shares
3,152,861
3,160,686
3,139,744
3,154,338
3,147,074